Patungan, Nahda M.
HRN: 21-13-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFUROXIME 1.5GM (VIAL)
12/12/2023
12/12/2023
IV
1.5gm
Now
T/c Incomplete Abortion
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes